Consultations

Search consultations and choose filters to show only the results you want

Filter search results

Consultation topic

Publication date

419 consultations

Equality and Human Rights Consultation - NICE TA - Trastuzumab Emtansine for Treating HER2 Positive Advanced Breast Cancer after Trastuzumab and a Taxane (Review of TA371)

Published 15 June 2017Closed

Equality and Human Rights Consultation - NICE TA - Pirfenidone for treating Idiopathic Pulmonary Fibrosis (Review of TA282)

Published 09 June 2017Closed

Equality and Human Rights Consultation - NICE TA - Adalimumab, Etanercept and Ustekinumab for Treating Severe, Chronic Plaque Psoriasis in Children and Young People

Published 09 June 2017Closed

Equality and Human Rights Consultation - NICE TA - Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma

Published 05 June 2017Closed

Equality and Human Rights Consultation - NICE TA - Adalimumab and Dexamethasone for Treating Non-Infectious Uveitis

Published 05 June 2017Closed

Equality and Human Rights Consultation - NICE NG 69 - Eating Disorders: Recognition and Treatment

Published 23 May 2017Closed

Equality and Human Rights Consultation - NICE TA - Etelcalcetide for treating secondary hyperparathyroidism

Published 19 May 2017Closed

Equality and Human Rights Consultation - NICE TA - Everolimus, Lutetium-177 DOTATATE and Sunitinib for Treating Unresectable or Metastatic Neuroendocrine Tumours with Disease Progression

Published 12 May 2017Closed

Equality and Human Rights Consultation - NICE TA - Brentuximab Vedotin for Treating CD30-Positive Hodgkin’s Lymphoma

Published 28 April 2017Closed

Equality and Human Rights Consultation - NICE TA - Blinatumomab for treating Philadelphia-chromosome-negative relapsed or refractory acute lymphoblastic leukaemia

Published 28 April 2017Closed

Equality and Human Rights Consultation - NICE TA - Ustekinumab for moderately to severely active Crohn’s disease after previous treatment

Published 28 April 2017Closed

Equality and Human Rights Consultation - NICE TA - Ponatinib for Treating Chronic Myeloid Leukaemia and Acute Lymphoblastic Leukaemia

Published 28 April 2017Closed

Equality and Human Rights Consultation - NICE TA - Certolizumab Pegol and Secukinumab for Treating Active Psoriatic Arthritis Following Inadequate Response to Disease Modifying Anti-Rheumatic Drugs

Published 24 April 2017Closed

Equality and Human Rights Consultation - NICE NG63 - Sexually Transmitted Infections: Condom Distribution Schemes

Published 06 April 2017Closed

Equality and Human Rights Consultation - NICE TA - Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer after Gemcitabine

Published 28 March 2017Closed

Equality and Human Rights Consultation - NICE NG 66 - Mental Health of Adults in Contact with the Criminal Justice System

Published 22 March 2017Closed

Equality and Human Rights Consultation - NICE TA - Daclizumab for Treating Relapsing-Remitting Multiple Sclerosis

Published 15 March 2017Closed

Equality and Human Rights Consultation - NICE TA - Ixekizumab for Treating Moderate to Severe Plaque Psoriasis

Published 10 March 2017Closed

Equality and Human Rights Consultation - NICE TA - Cetuximab and Panitumumab for Previously Untreated Metastatic Colorectal Cancer (Review of TA176 & Part Review of TA240)

Published 02 March 2017Closed

Equality and Human Rights Consultation - NICE TA - Obeticholic Acid for Treating Primary Biliary Cholangitis

Published 02 March 2017Closed

Pages

Back to top